Home068270 β’ KRX
add
Celltrion Inc
Previous close
β©197,200.00
Day range
β©200,000.00 - β©207,000.00
Year range
β©144,615.31 - β©251,000.00
Market cap
47.60T KRW
Avg Volume
560.82K
P/E ratio
44.21
Dividend yield
0.36%
In the news
Financials
Income Statement
Revenue
Net income
| (KRW) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 1.33T | 25.06% |
Operating expense | 383.06B | 10.26% |
Net income | 528.43B | 123.30% |
Net profit margin | 39.73 | 78.56% |
Earnings per share | 2.40K | 117.62% |
EBITDA | 537.36B | 95.28% |
Effective tax rate | -0.01% | β |
Balance Sheet
Total assets
Total liabilities
| (KRW) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.24T | 8.40% |
Total assets | 22.33T | 6.08% |
Total liabilities | 4.98T | 43.37% |
Total equity | 17.35T | β |
Shares outstanding | 218.61M | β |
Price to book | 2.51 | β |
Return on assets | 5.42% | β |
Return on capital | 5.77% | β |
Cash Flow
Net change in cash
| (KRW) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 528.43B | 123.30% |
Cash from operations | 139.88B | -54.28% |
Cash from investing | -629.48B | -520.17% |
Cash from financing | 754.75B | 429.67% |
Net change in cash | 309.21B | 1,200.88% |
Free cash flow | -160.53B | -362.61% |
About
Celltrion, Inc. is a biopharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion. Celltrion's founder, Seo Jung-jin, is the richest person in South Korea. Seo Jung-jin, its founder was awarded the 2021 EY World Entrepreneur Of The Year. Wikipedia
CEO
Founded
2002
Website
Employees
1,074
